Several studies have shown that osthole can treat NAFLD by upregulating PPAR-α and downregulating liver proteins like NF-κB, SREBP1c, and FAS, which ultimately reduces liver steatosis and inflammation [144,163]. The gene discussed is FAS; the disease is Hepatic steatosis.